Daniel A. Pollyea, MD, MS | Authors

Articles

Biomarker Testing in AML

September 24, 2021

Daniel Pollyea, MD, MS, explains the risk factors for acute myeloid leukemia, the importance of biomarker testing, and the challenges that prevent every patient from being tested.